References
- Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
- Epidemiology Working Group for NCIP Epidemic Response, Chinese CDC. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) –China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151. doi:10.3760/cma.j.issn.0254-6450.2020
- Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9
- Saudi Center for Disease Control and Prevention. Quick interim guide to COVID-19 surveillance case definitions and disposition; April, 2020. Available from: https://covid19.cdc.gov.sa. Accessed September 16, 2021.
- Chau-Etchepare F, Hoerger JL, Kuhn BT, et al. Viruses and non-allergen environmental triggers in asthma. J Investig Med. 2019;67(7):1029–1041. doi:10.1136/jim-2019-001000
- James P, Cornish A, Brady K, et al. Is there benefit in identifying asthma triggers during an exacerbation? Clin Pediatr (Phila). 2020;59(2):142–147. doi:10.1177/0009922819887399
- Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–834. doi:10.1016/S0140-6736(10)61380-3
- Cao L, Lee S, Krings JG, et al. Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(5):535–541.e2. doi:10.1016/j.anai.2021.02.020
- Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663–1665. doi:10.1056/NEJMc2005073
- Asseri AA, Alzaydani I, Al-Jarie A, et al. Clinical characteristics and laboratory abnormalities of hospitalized and critically ill children with coronavirus disease 2019: a Retrospective Study from Saudi Arabia. Int J Gen Med. 2021;14:1949–1958. doi:10.2147/IJGM.S311831
- Papadopoulos NG, Mathioudakis AG, Custovic A, et al. Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multi-national cohort. Allergy. 2021;76(6):1765–1775. doi:10.1111/all.14787
- Dosanjh A. COVID 19 and pediatric asthma. J Asthma Allergy. 2020;13:647–648. doi:10.2147/JAA.S291796
- Castro-Rodriguez JA, Forno E. Asthma and COVID-19 in children: a systematic review and call for data. Pediatr Pulmonol. 2020;55(9):2412–2418. doi:10.1002/ppul.24909
- Ali AS, Al-Hakami AM, Shati AA, Asseri AA, Al-Qahatani SM. Salient conclusive remarks on epidemiology and clinical manifestations of pediatric COVID-19: narrative review. Front Pediatr. 2020;8:584694. doi:10.3389/fped.2020.584694
- Zheng F, Liao C, Fan Q-H, et al. Clinical characteristics of children with coronavirus disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–280. doi:10.1007/s11596-020-2172-6
- Lipworth B, Chan R, RuiWen Kuo C. Type 2 asthma inflammation and COVID-19: a double edged sword. J Allergy Clin Immunol Pract. 2021;9(3):1163–1165. doi:10.1016/j.jaip.2020.12.033
- Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146(6):1295–1301. doi:10.1016/j.jaci.2020.09.017
- Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 2021;9(3):1152–1162.e3. doi:10.1016/j.jaip.2020.12.045
- Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. prevalence and risk of severe disease. Am J Respir Crit Care Med. 2021;203(7):893–905. doi:10.1164/rccm.202008-3266OC
- Eggert LE, He Z, Collins W, et al. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19 [published online ahead of print, 2021 Jun 3]. Allergy. 2021;10(1):1–13. doi:10.1111/all.14972
- Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22–37. doi:10.1164/rccm.201611-2232PP
- Chatziparasidis G, Kantar A. COVID-19 in children with asthma. Lung. 2021;199(1):7–12. doi:10.1007/s00408-021-00419-9
- Abrams EM, Sinha I, Fernandes RM, Hawcutt DB. Pediatric asthma and COVID-19: the known, the unknown, and the controversial. Pediatr Pulmonol. 2020;55(12):3573–3578. doi:10.1002/ppul.25117
- Metbulut AP, Mustafaoğlu Ö, Şen G, et al. Evaluation of the clinical and laboratory findings of asthmatic children with SARS-CoV-2 infection [published online ahead of print, 2021 Jun 24]. Int Arch Allergy Immunol. 2021:1–8. doi:10.1159/000517153
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (2021 update). Available from: www.ginasthma.org. Accessed May 24, 2021.
- Saudi MoH protocol for adults patients suspected of confirmed with COVID-19; 2020. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf. Accessed April 26, 2021.
- Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. COVID-19 and pediatric asthma: clinical and management challenges. Int J Environ Res Public Health. 2021;18(3):1093. doi:10.3390/ijerph18031093
- Skevaki C, Karsonova A, Karaulov A, et al. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat Rev Immunol. 2021;21(4):202–203. doi:10.1038/s41577-021-00516-z
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
- Ho KS, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol. 2021;127(1):42–48. doi:10.1016/j.anai.2021.02.021
- Zeiger RS, Schatz M, Li Q. The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma. J Allergy Clin Immunol Pract. 2015;3(2):283–287.e4. doi:10.1016/j.jaip.2014.10.009
- Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL; Childhood Asthma Management Program Research Group. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest. 2011;140(1):100–107. doi:10.1378/chest.10-2794
- Asseri AA. Predictors of pediatric intensive care unit admissions among children with acute asthma exacerbation. Middle East J Fam Med. 2020;18(3):20–26. doi:10.5742/MEWFM.2020.93771
- Shah SP, Grunwell J, Shih J, Stephenson S, Fitzpatrick AM. Exploring the utility of noninvasive type 2 inflammatory markers for prediction of severe asthma exacerbations in children and adolescents. J Allergy Clin Immunol Pract. 2019;7(8):2624–2633.e2. doi:10.1016/j.jaip.2019.04.043
- Tang HHF, Lang A, Teo SM, et al. Developmental patterns in the nasopharyngeal microbiome during infancy are associated with asthma risk. J Allergy Clin Immunol. 2021;147(5):1683–1691. doi:10.1016/j.jaci.2020.10.009
- Sajuthi SP, DeFord P, Li Y, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020;11(1):5139. doi:10.1038/s41467-020-18781-2
- Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage. Nat Med. 2007;13(2):139–145. doi:10.1038/nm1551
- Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1–9. doi:10.12932/AP-200220-0772
- Hu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA Jr, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146(2):327–329.e4. doi:10.1016/j.jaci.2020.06.001
- Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65(5):384–390. doi:10.1136/thx.2009.126722
- Thaweerujirot C, Daengsuwan T. Comparison between pediatric respiratory assessment measure (PRAM) score and Wood’s asthma score to assess acute asthma exacerbation. Asian Pac J Allergy Immunol. 2019;37(3):123–129. doi:10.12932/AP-060118-0232
- Lee DS, Gross E, Hotz A, Rastogi D. Comparison of severity of asthma hospitalization between African American and Hispanic children in the Bronx. J Asthma. 2020;57(7):736–742. doi:10.1080/02770903.2019.1609981
- Munoz FA, Benton LD, Kops SA, Kowalek KA, Seckeler MD. Greater length of stay and hospital charges for severe asthma in children with depression or anxiety. Pediatr Pulmonol. 2020;55(11):2908–2912. doi:10.1002/ppul.25061
- Drewek R, Mirea L, Rao A, Touresian P, Adelson PD. Asthma treatment and outcomes for children in the emergency department and hospital. J Asthma. 2018;55(6):603–608. doi:10.1080/02770903.2017.1355381
- Rutman L, Atkins RC, Migita R, et al. Modification of an established pediatric asthma pathway improves evidence-based, efficient care. Pediatrics. 2016;138(6):e20161248. doi:10.1542/peds.2016-1248
- Farber HJ, Silveira EA, Vicere DR, Kothari VD, Giardino AP. Oral corticosteroid prescribing for children with asthma in a medicaid managed care program. Pediatrics. 2017;139(5):e20164146. doi:10.1542/peds.2016-4146
- Silber JH, Rosenbaum PR, Calhoun SR, et al. Racial disparities in medicaid asthma hospitalizations. Pediatrics. 2017;139(1):e20161221. doi:10.1542/peds.2016-1221